摘要
目的:探讨扶正解毒通络方对肝癌HepG2细胞侵袭作用和基质金属蛋白酶(Matrix metallo proteinases,MMP)-2、MMP-9表达水平的影响及可能的作用机制。方法:CCK8实验检测扶正解毒通络方对HepG2细胞活性影响;Transwell侵袭实验检测扶正解毒通络方对HepG2侵袭能力的影响;ELISA法检测扶正解毒通络方干预HepG2细胞后MMP-2和MMP-9的表达水平。结果:CCK8实验结果显示,扶正解毒通络方对HepG2细胞意志呈剂量时间相关性。Transwell侵袭实验显示,2.65 mg/ml扶正解毒通络方对HepG2细胞侵袭力抑制率为52.45%(P<0.05)。ELISA检测结果显示,扶正解毒通络方干预后HepG2细胞上清液中MMP-2和MMP-9表达水平下降(P<0.05)。结论:扶正解毒通络方可以抑制肝癌HepG2细胞的生长和侵袭,其机制可能是通过下调MMP-2、MMP-9在肝癌细胞HepG2的表达。
Objective: To investigate the effect and mechanism of Fuzheng Jiedu Tongluofang on the expression of MMP-2,MMP-9 and invasion of human hepatoma HepG2 cell. Methods: Hepatioma HepG2 cell was treated with Fuzheng Jiedu Tongluofang.The cell viability was measured by CCK8. The invasion of HepG2 was detected by Transwell assay. The expression of MMP-2 and MMP-9 was analyzed by ELISA. Results: In the CCK8 assay,Fuzheng Jiedu Tongluofang could inhibit the proliferation of HepG2 cells at a density and time measure. In the Transwell assay,the inhibitory rate of invasion was 52. 45% when treated with Fuzheng Jiedu Tongluofang at a concentration of 2. 65 mg/ml. The ELISA assay indicated that the expression of MMP-2 and MMP-9 decreased significantly after treated with Fuzheng Jiedu Tongluofang( P0. 05). Conclusion: Fuzheng Jiedu Tongluofang suppressed the invasion of HepG2 with the possible mechanism of down-regulating the expression of MMP-2 and MMP-9 in HepG2.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2017年第4期542-544,共3页
Chinese Journal of Immunology
基金
吉林省科技发展规划项目(330201Q00)资助